Abstract of Technology Project

Project Name Evaluation of the efficacy and safety of a short-course, daily, 4-month regimen including isoniazid, pyrazinamide, rifapentine and moxifloxacin (2HZPM/2HPM) for the treatment of drug-susceptible pulmonary tuberculosis in Taiwan (ESCAPE-TB)
Department Kaohsiung Veterans General Hospital Project Year 110
Project No. MOHW110-CDC-C-114-000115 Project Host Shin-Jung Lee
Tag Active TB;short course regimen;adverse reaction;completion rate;treatment interruption;
File MOHW110-CDC-C-114-000115.pdf